Aibotics Inc. (AIBT)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0001 (11.11%)
May 27, 2026, 1:58 PM EST
Aibotics Market Cap
Aibotics has a market cap or net worth of $617.81 thousand as of May 27, 2026. Its market cap has decreased by -8.97% in one year.
Market Cap
617.81K
Enterprise Value
1.65M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 617.81K, a decrease of -98.53%. That is a compound annual growth rate of -54.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 617.81K | -49.25% |
| Dec 31, 2025 | 1.22M | 1,088.20% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
| Jan 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagenic Therapeutics | 1.12M |
| Evofem Biosciences | 980.72K |
| CERo Therapeutics Holdings | 969.90K |
| Halberd | 896.76K |
| Agentix | 881.47K |
| Avenue Therapeutics | 793.72K |
| SQZ Biotechnologies Company | 707.79K |
| Emmaus Life Sciences | 680.83K |